Top 5 Seizure and Epilepsy Apps for Primary Care

June 26th 2025

Distress Signals: How to Help a Clinician Colleague in Need

Suboptimal adherence with antidementia drugs is associated with poorer clinical outcomes including accelerated disease progression and symptomatology.

February 14th 2023

Atogepant Superior to Topiramate for Migraine Prevention in Phase 3 Head-to-Head TEMPLE Study

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

June 18th 2025

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

The superior tolerability and efficacy of the CGRP-targeting atogepant supports recent calls from the AHS to consider the class as first-line preventive therapy for migraine.

September 29th 2022

What, Exactly, is Alcohol Use Disorder?

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

Solriamfetol Improves OSA-Related Cognitive Deficits Independent of Sleepiness Reduction

AUD affects 15 million Americans, with men nearly 2 times more vulnerable to the disease vs women. Are you tracking signs and symptoms in your patients?

Only Half of Patients Adherent to Antidementia Medication Regimens at 1 Year: New Meta-Analysis Results

Solriamfetol's significant cognitive benefits may be the result of mechanisms operating independently of its wake-promoting effects, study authors suggest.

Related Content

June 26th 2025

Distress Signals: How to Help a Clinician Colleague in Need

Suboptimal adherence with antidementia drugs is associated with poorer clinical outcomes including accelerated disease progression and symptomatology.

February 14th 2023

Atogepant Superior to Topiramate for Migraine Prevention in Phase 3 Head-to-Head TEMPLE Study

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

June 18th 2025

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

The superior tolerability and efficacy of the CGRP-targeting atogepant supports recent calls from the AHS to consider the class as first-line preventive therapy for migraine.

September 29th 2022

What, Exactly, is Alcohol Use Disorder?

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

Solriamfetol Improves OSA-Related Cognitive Deficits Independent of Sleepiness Reduction

AUD affects 15 million Americans, with men nearly 2 times more vulnerable to the disease vs women. Are you tracking signs and symptoms in your patients?